DK156649C - Analogifremgangsmaade til fremstilling af 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-alkylpiperidiniumhalogenider eller 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-benzylpiperidiniumhalogenider - Google Patents

Analogifremgangsmaade til fremstilling af 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-alkylpiperidiniumhalogenider eller 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-benzylpiperidiniumhalogenider

Info

Publication number
DK156649C
DK156649C DK429382A DK429382A DK156649C DK 156649 C DK156649 C DK 156649C DK 429382 A DK429382 A DK 429382A DK 429382 A DK429382 A DK 429382A DK 156649 C DK156649 C DK 156649C
Authority
DK
Denmark
Prior art keywords
aminoaaphenylaaethylaa
methoxybenzoyl
methyl
benzylpiperidiniumhalogenider
analogifremgangsmaade
Prior art date
Application number
DK429382A
Other languages
English (en)
Other versions
DK429382A (da
DK156649B (da
Inventor
John E Lawson
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of DK429382A publication Critical patent/DK429382A/da
Publication of DK156649B publication Critical patent/DK156649B/da
Application granted granted Critical
Publication of DK156649C publication Critical patent/DK156649C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK429382A 1981-01-28 1982-09-27 Analogifremgangsmaade til fremstilling af 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-alkylpiperidiniumhalogenider eller 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-benzylpiperidiniumhalogenider DK156649C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US06/229,244 US4321386A (en) 1981-01-28 1981-01-28 Quaternary piperidinium halides
US22924481 1981-01-28
PCT/US1982/000108 WO1982002551A1 (en) 1981-01-28 1982-01-27 Quaternary piperidinium halides
US8200108 1982-01-27

Publications (3)

Publication Number Publication Date
DK429382A DK429382A (da) 1982-09-27
DK156649B DK156649B (da) 1989-09-18
DK156649C true DK156649C (da) 1990-02-05

Family

ID=22860396

Family Applications (1)

Application Number Title Priority Date Filing Date
DK429382A DK156649C (da) 1981-01-28 1982-09-27 Analogifremgangsmaade til fremstilling af 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-alkylpiperidiniumhalogenider eller 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-benzylpiperidiniumhalogenider

Country Status (19)

Country Link
US (1) US4321386A (da)
JP (1) JPH0348904B2 (da)
AR (1) AR230266A1 (da)
AT (1) AT378183B (da)
AU (1) AU551523B2 (da)
BE (1) BE891938A (da)
CA (1) CA1184917A (da)
CH (1) CH651021A5 (da)
DE (1) DE3223499T1 (da)
DK (1) DK156649C (da)
FI (1) FI65239C (da)
GB (1) GB2100736B (da)
GR (1) GR74720B (da)
IE (1) IE52420B1 (da)
IT (1) IT1147809B (da)
NL (1) NL8220049A (da)
SE (1) SE435057B (da)
WO (1) WO1982002551A1 (da)
YU (1) YU43063B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102458435A (zh) * 2009-04-09 2012-05-16 考格尼申治疗股份有限公司 认知衰退的抑制剂
WO2011014880A1 (en) 2009-07-31 2011-02-03 Cognition Therapeutics, Inc. Inhibitors of cognitive decline
JP2014511373A (ja) 2011-02-02 2014-05-15 コグニション セラピューティクス インク. ウコン油から単離された化合物およびその使用方法
US9796672B2 (en) 2014-01-31 2017-10-24 Cognition Therapeutics, Inc. Isoindoline compositions and methods for treating neurodegenerative disease
MX2019013524A (es) 2017-05-15 2020-02-10 Cognition Therapeutics Inc Composiciones para tratar enfermedades neurodegenerativas.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3037910A (en) * 1958-04-18 1962-06-05 Burroughs Wellcome Co Process for treatment of hypertension
US3931195A (en) * 1971-03-03 1976-01-06 Mead Johnson & Company Substituted piperidines
US3917679A (en) * 1974-04-12 1975-11-04 Lilly Co Eli Quaternary ammonium salts of N-dialkylaminoalkyl-N-(2-indanyl)anilines

Also Published As

Publication number Publication date
JPS57502216A (da) 1982-12-16
GR74720B (da) 1984-07-10
BE891938A (fr) 1982-07-28
SE8205535D0 (sv) 1982-09-28
AT378183B (de) 1985-06-25
SE435057B (sv) 1984-09-03
ATA900782A (de) 1984-11-15
IT8247667A0 (it) 1982-01-28
NL8220049A (nl) 1982-11-01
IE820191L (en) 1982-07-28
YU19782A (en) 1985-04-30
DK429382A (da) 1982-09-27
CH651021A5 (de) 1985-08-30
YU43063B (en) 1989-02-28
US4321386A (en) 1982-03-23
FI822443A0 (fi) 1982-07-08
DE3223499C2 (da) 1989-11-23
FI65239B (fi) 1983-12-30
DK156649B (da) 1989-09-18
JPH0348904B2 (da) 1991-07-25
GB2100736B (en) 1985-01-30
AU551523B2 (en) 1986-05-01
AU8148582A (en) 1982-08-16
WO1982002551A1 (en) 1982-08-05
FI65239C (fi) 1984-04-10
IE52420B1 (en) 1987-10-28
DE3223499T1 (de) 1983-01-13
IT1147809B (it) 1986-11-26
AR230266A1 (es) 1984-03-01
FI822443L (fi) 1982-07-08
CA1184917A (en) 1985-04-02
GB2100736A (en) 1983-01-06
SE8205535L (sv) 1982-09-28

Similar Documents

Publication Publication Date Title
DK280182A (da) Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK491682A (da) Fremgangsmaade til fremstilling af substituerede benzimidazoler
DK444682A (da) Fremgangsmaade til fremstilling af peptider
DK350083D0 (da) Fremgangsmade til fremstilling af phenylethanolaminer
DK81082A (da) Fremgangsmaade til fremstilling af polypeptider
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK161831C (da) Fremgangsmaade til fremstilling af alpha-chlorerede_chlorformiater
DK475882A (da) Fremgangsmaade til fremstilling af benzofuranoner
DK312082A (da) Fremgangsmaade til fremstilling af benzothiazolsulfonamidderivater
DK299483A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK553582A (da) Fremgangsmaade til fremstilling af naphthoxyalkylaminer
DK370582A (da) Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid
DK283083A (da) Fremgangsmaade til fremstilling af n-phosphonomethylglycin
DK451883D0 (da) Fremgangsmade til fremstilling af 4-methyl-5-alkylthiometyl-imidazoler
DK156649C (da) Analogifremgangsmaade til fremstilling af 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-alkylpiperidiniumhalogenider eller 2-oe2-oe2-oe(4-methoxybenzoyl)aminoaaphenylaaethylaa-1-methyl-1-benzylpiperidiniumhalogenider
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK361983A (da) Fremgangsmaade til fremstilling af meldroejealkaloider
DK394783D0 (da) Fremgangsmade til fremstilling af n-phosphonometylglycin
DK335382A (da) Fremgangsmaade til fremstilling af 3-brom-4-fluorbenzaldehyd
DK399783D0 (da) Fremgangsmade til fremstilling af substituerede 1-puridyloxy-3-indolylalkylamino-2-propanoler
DK57182A (da) Fremgangsmaade til fremstilling af benzopyranoimidazoler ellersyreadditionssalte eller metalsalte deraf
DK385983D0 (da) Fremgangsmade til fremstilling af 1-oxacephamer
FI820516L (fi) Anordning foer framstaellning av rengoeringsvaetska avfettningsvaetska eller liknande
DK231482A (da) Fremgangsmaade til fremstilling af beta-lactamringholdige derivater
DK193983D0 (da) Fremgangsmade til fremstilling af substituerede phenylendiaminer

Legal Events

Date Code Title Description
PBP Patent lapsed